Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 144
Filter
1.
Rev. cuba. ortop. traumatol ; 36(1)abr. 2022. ilus, tab
Article in Spanish | LILACS, CUMED | ID: biblio-1409047

ABSTRACT

Introducción: En los últimos años la anestesia local sin torniquete y con el paciente despierto, técnica conocida por WALANT (por sus siglas en inglés), ha ganado mucha popularidad en las cirugías de la mano y la muñeca. Objetivo: Reportar nuestra experiencia con el uso de la técnica WALANT, a fin de prescindir del uso del torniquete en las cirugías de la mano. Métodos: En noviembre del 2020 fueron intervenidos 30 pacientes por diversas enfermedades ortopédicas, entre las que figuraron: dedos en resorte, síndrome del túnel carpiano, tenovaginitis estenosante del pulgar, gangliones del carpo y amputación del tercer radio por rigidez en extensión postraumática, entre otras. Para la evaluación de la técnica tuvimos en cuenta: tiempo quirúrgico, magnitud del sangrado, dolor durante la infiltración anestésica, la intervención, y en las primeras 24 horas del postoperatorio, la necesidad de refuerzo anestésico, uso de isquemia, complicaciones y nivel de satisfacción del paciente. Resultados: Los resultados obtenidos con esta técnica anestésica son semejantes a otras, con las ventajas que el sangrado es leve, no hay que utilizar isquemia, el tiempo quirúrgico es menor y el efecto anestésico duró entre 10 y 12 horas en todos los pacientes. En ninguno de los pacientes hubo necesidad de refuerzo anestésico. Conclusiones: Se demuestra la efectividad de la técnica WALANT en las cirugías de mano. Con ella se disminuye el gasto de materiales para el acto quirúrgico, así como de personal, es de fácil aplicación y disminuyen las sensaciones desagradables y los peligros del uso de isquemia en los pacientes(AU)


Introduction: Currently, the use of local anaesthetic with no tourniquet and wide awake patient (Wide Awake Local Anaesthetic No Tourniquet - WALANT) has gained popularity in surgeries of the hand and wrist. Objective: To report our experience in the use of WALANT technique in order to discard the use of tourniquet in hand surgeries. Method: In November 2020, thirty patients underwent surgery due to different orthopaedic conditions, among them trigger fingers, carpal tunnel syndrome, stenosing tenovaginitis of the thumb, carpal ganglion and amputation of the third radius due to post trauma stiffness, among others. In order to assess this technique, we considered surgical time, volume of bleeding, pain during anesthetic infiltration, intervention and the need for additional anesthetic during the first 24 hours after surgery; we considered also ischemia, complications and level patient´s satisfaction. Results: This technique had similar results to others; however, the bleeding is mild, there is no need for ischemia, the surgical time is lesser and the anesthetic effect lasted 10 to 12 hours in all patients. None of them required additional anesthetic. All subjects felt the initial infiltration but none complained of pain during the rest of the anesthetic injection or during the surgical act. There were no complications. Conclusions: The effectiveness of WALANT technique in hand surgeries is shown. The cost of materials for the surgical act is reduced with it, as well as the surgical staff, it is easy to use and unpleasant sensations and dangers of the use of ischemia in patients are reduced(AU)


Subject(s)
Humans , Bone Neoplasms/surgery , Epinephrine/administration & dosage , Sodium Bicarbonate/administration & dosage , Hand/surgery , Lidocaine/administration & dosage , Wrist/surgery , Effectiveness
2.
Einstein (Säo Paulo) ; 18: eRW5055, 2020. tab, graf
Article in English | LILACS | ID: biblio-1056057

ABSTRACT

ABSTRACT The objective of the present study was to assess the efficacy of different doses, times for infusion of the first dose, intervals of administration of subsequent doses, and number of epinephrine doses in the survival of children and adolescents who went into cardiorespiratory arrest. It is a review study with data from the PubMedⓇ/MEDLINEⓇdatabase. The search was for articles published from January 1st, 2000 to February 10, 2019, with a sample of patients aged under 18 years, published in English, Portuguese and Spanish. We found 222 articles, of which 16 met the inclusion criteria of the study. The first dose should be given as soon as possible. The standard dose (0.01mg/kg) has a better outcome when compared to the higher dose (0.1mg/kg). There is an iⓇverse relation between the number of epinephrine doses and survival. The interval currently recommended between doses has lower survival when compared to larger intervals. The dosage recommended by the American Heart Association presents a better outcome for survival, but the interval between doses and the maximum number of doses should be better assessed.


RESUMO O objetivo deste estudo foi avaliar a eficácia de diferentes doses, tempos para infusão da primeira dose, intervalos de administração de doses subsequentes e número de doses de epinefrina na sobrevida de crianças e adolescentes que sofreram parada cardiorrespiratória. Trata-se de estudo de revisão, cujas buscas foram feitas na base de dados PubMedⓇ /MEDLINEⓇ. Foram selecionados artigos publicados de 1° de janeiro de 2000 até 10 de fevereiro de 2019, realizados em menores de 18 anos de idade, publicados em inglês, português e espanhol. Foram encontrados 222 artigos, dos quais 16 atenderam os critérios de inclusão no estudo. A primeira dose deve ser aplicada o mais rápido possível. A dose padrão (0,01mg/kg) apresenta melhor desfecho quando comparada à dose alta (0,1mg/kg). Houve relação inversa entre número de doses de epinefrina e sobrevida. O intervalo entre doses recomendado atualmente apresenta menor sobrevida quando comparado a intervalos maiores. A dose recomendada pela American Heart Association apresenta melhor desfecho para sobrevida, porém o intervalo entre doses e o número máximo de doses devem ser melhor avaliados.


Subject(s)
Humans , Male , Female , Child , Adolescent , Epinephrine/administration & dosage , Adrenergic alpha-Agonists/administration & dosage , Heart Arrest/drug therapy , Time Factors , Dose-Response Relationship, Drug , Heart Arrest/mortality
4.
Evid. actual. práct. ambul ; 22(1): e001077, abr. 2019. tab.
Article in Spanish | LILACS | ID: biblio-1015125

ABSTRACT

La bronquiolitis es una infección respiratoria aguda baja de causa viral, de aparición invernal, que es común en bebés de 0a 12 meses de edad. Conduce a que las vías respiratorias pequeñas se inflamen y se llenen de desechos, obstruyéndose.El bebé tiene una tos fuerte, secreción nasal, generalmente fiebre y puede presentar sibilancias dificultad respiratoria ydesaturación de oxígeno. Tras la presentación de un caso en la guardia se generó una controversia científica sobre lautilidad de los broncodilatadores en pacientes con bronquiolitis. Luego de realizar una búsqueda bibliográfica y seleccionarla evidencia más reciente y de mejor calidad, se concluye que la evidencia no apoya el uso de broncodilatadores enpacientes con bronquiolitis.(AU)


Bronchiolitis is a low acute respiratory lower respiratory tract infection of viral origin, winter appearance, which is commonin babies from 0 to 12 months of age. It causes the small airways in the lungs to become inflamed and fill with debris. Theinfant has a harsh cough, runny nose, usually fever and may have wheezing, respiratory distress and oxygen desaturation.After the presentation of a case in the emergency department, a scientific controversy was generated about the usefulnessof bronchodilators in patients with bronchiolitis. After conducting a literature search and selecting the most recent and bestquality evidence, it is concluded that evidence does not support the use of bronchodilators in patients with bronchioliTIS.(AU)


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Bronchodilator Agents/administration & dosage , Bronchiolitis/drug therapy , Epinephrine/administration & dosage , Albuterol/administration & dosage , Respiratory Tract Infections/drug therapy , Bronchodilator Agents/adverse effects , Bronchodilator Agents/therapeutic use , Bronchiolitis/diagnosis , Epinephrine/adverse effects , Respiratory Sounds/diagnosis , Cough/prevention & control , Albuterol/adverse effects , Albuterol/therapeutic use , Fever/prevention & control
5.
Int. j. morphol ; 37(1): 344-348, 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-990049

ABSTRACT

RESUMEN: El proceso angiogénico se define como el proceso en el que los vasos sanguíneos generan brotes dando como resultado neovascularidad. Un desbalance en el proceso angiogénico contribuye a numerosos desórdenes inflamatorios, infecciosos, isquémicos, inmunológicos y malignos. En el territorio maxilofacial se pueden encontrar patologías neoplásicas benignas de desarrollo local con un marcado componente angiogénico que determinan su crecimiento y agresividad. Sin embargo, existe escasa evidencia de cómo tratarlas en base al control de la angiogénesis. Terry & Jacoway (1994) desarrollaron un protocolo de tratamiento para lesiones neoplásicas benignas con un importante componente vascular que se utiliza actualmente. Este protocolo consiste en la infiltración intralesional de una suspensión de triamcinolona 10 mg/ml más una solución de anestésico local de uso odontológico como la lidocaína al 2 % asociada a epinefrina en una concentración de 1:200.000. Sin embargo, el uso de epinefrina podría disminuir la acción antiangiogénica de la triamcinolona al ser un vasoconstrictor. El objetivo de este estudio es comparar el efecto antiangiogénico, en la membrana alantocoriónica de pollo (MAC), de esta suspensión versus el efecto de la triamcinolona sin asociar a anestésicos locales. Los resultados del efecto antiangiogénico en la MAC de pollo, obtenidos en la investigación concluyeron que la suspensión de triamcinolona asociada a lidocaína con epinefrina es similar al de la suspensión de triamcinolona sin asociar a anestésicos locales. Además, se logró determinar que las suspensiones de triamcinolona sin asociar a anestésicos locales y las asociadas a anestésicos locales con o sin vasoconstrictor poseen un marcado efecto antiangiogénico, en la MAC de pollo, en comparación al grupo control.


SUMMARY: Angiogenesis is defined as the process through which new blood vessels form from previously existing vessels. Several inflammatory, infectious, ischemic, immunological and malignant disorders are caused by the lack of adequate angiogenesis balance. In the maxillofacial area, there are invasive benign neoplastic pathologies with a strong angiogenic component, which determines aggressive behavior and growth. Studies in the literature are scarce regarding treatment of these conditions based on angiogenesis control. Currently, the protocol used to treat these maxillofacial benign neoplastic lesions, was developed in 1994 by Terry & Jacoway and has a strong angiogenic component. Consequently lesions are treated via intra-lesion administration of triamcinolone 10 mg / mL, a solution used in dental local anesthetic, such as lidocaine 2 %, in conjunction with epinephrine at a concentration of 1:200,000. The objective of this study was to compare the antiangiogenic effect of this protocol in chicken chorioallantoic membrane (CAM) without the use of local anesthetic. The results of the antiangiogenic effect in the CAM obtained in this study concluded that the effect of the suspension of triamcinolone associated to lidocaine with epinephrine, is similar to the suspension of triamcinolone without associating local anesthetics. Furthermore, it was determined that suspensions of triamcinolone without local anesthetic, and those associated to local anesthetic with, and without vasoconstrictor have a strong antiangiogenic effect in CAM compared to the control group.


Subject(s)
Animals , Chick Embryo , Triamcinolone/administration & dosage , Epinephrine/administration & dosage , Angiogenesis Inhibitors/administration & dosage , Chorioallantoic Membrane/drug effects , Lidocaine/administration & dosage , Anesthetics, Local/administration & dosage , Neovascularization, Pathologic
6.
Braz. j. med. biol. res ; 51(9): e7627, 2018. graf
Article in English | LILACS | ID: biblio-951764

ABSTRACT

Uterine leiomyomas (ULs) are benign monoclonal tumors that arise from the underlying myometrial tissue in the uterus. Effective therapies are still lacking because of poor understanding of the pathophysiology and epidemiology. Hence, it is urgent to establish efficient animal models to screen novel anti-UL therapies. In this study, for the first time, traditional Chinese medicine and Western medicine were combined to establish an animal model of ULs in rats. In order to evaluate the function and value of the novel model, it was compared with other models. The long-term and short-term rat models for ULs were established using progesterone and diethylstilbestrol. Rats in Qi stagnation and blood stasis group were injected with epinephrine hydrochloride and received chronic unpredictable stress for two weeks. Rats in combining disease with syndrome group (CDWSG) received not only epinephrine hydrochloride injection and chronic unpredictable stress but also progesterone and diethylstilbestrol treatment. We analyzed differences in organ coefficient, uterus size, uterine pathology, concentrations of progesterone, estradiol, progesterone receptor, estrogen receptor, expression of desmin, α-smooth muscle actin, and vimentin among the five groups. The animal model of ULs was successfully constructed by loading the rats with estrogen and progesterone. The rat model of CDWSG was more stable than other groups and the method was the most efficient.


Subject(s)
Animals , Female , Rats , Uterine Neoplasms/chemically induced , Disease Models, Animal , Leiomyoma/chemically induced , Medicine, Chinese Traditional , Progesterone/administration & dosage , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Epinephrine/administration & dosage , Rats, Sprague-Dawley , Diethylstilbestrol/administration & dosage
7.
Einstein (Säo Paulo) ; 15(4): 500-506, Oct.-Dec. 2017. tab
Article in English | LILACS | ID: biblio-891440

ABSTRACT

ABSTRACT Anaphylaxis is a severe, life-threatening generalized or systemic hypersensitivity reaction that requires rapid and adequate care. This study aimed to obtain an integrated view of the level of physicians' knowledge related with treatment of anaphylaxis in studies published within the last 5 years. Sixteen studies were found and four points were identified as of the great interest to the authors: (1) emergency pharmacological treatment, (2) epinephrine auto-injectors prescription, (3) knowledge of the main signs of anaphylaxis, and (4) admission of the patient to verify biphasic reactions. Concern about the use of intramuscular adrenaline as the first choice in relation with anaphylaxis was evident in most studies, rather than its use in the comparison dial, and especially low in a study that included data from Brazil, in which the frequency of its use was 23.8%. An adrenaline autoinjector is highly recommended among specialists for patients at risk of anaphylaxis, however, its use is still infrequent among non-specialists and in countries that this agent is not available. Intervention studies have shown improved medical knowledge of anaphylaxis following disclosure of the information contained in the international guidelines. The analysis of these studies reinforces the need to disseminate international guidelines for diagnosis and treatment of anaphylaxis, as well as providing an adrenaline autoinjector, to improve management and to prevent a fatal outcome.


RESUMO Anafilaxia é uma reação de hipersensibilidade generalizada ou sistêmica grave, com risco de morte, que exige atendimento rápido e correto. Este estudo teve como objetivo obter uma visão integrada do nível de conhecimento dos médicos no atendimento da anafilaxia à luz dos estudos publicados internacionalmente nos últimos 5 anos. Foram encontrados 16 estudos, com quatro pontos identificados como de maior interesse dos autores: (1) tratamento farmacológico de emergência, (2) prescrição de autoinjetores de adrenalina, (3) conhecimento dos principais indícios da anafilaxia e (4) observação do paciente para verificar reações bifásicas. A preocupação com o uso da adrenalina intramuscular como primeira escolha frente à anafilaxia foi evidente na maioria dos estudos, mas o conhecimento sobre seu uso se mostrou desigual e especialmente baixo em estudo que incluiu dados do Brasil, onde a frequência de seu uso foi de 23,8%. A adrenalina autoinjetável é altamente recomendada entre especialistas para pacientes em risco de anafilaxia, mas seu uso ainda é pouco frequente entre não especialistas e em países que não dispõem dela em seus mercados internos. Estudos de intervenção comprovaram a melhora no entendimento dos médicos sobre anafilaxia após a divulgação das informações contidas nas diretrizes internacionais. A análise dos estudos reforça a necessidade de disseminar as diretrizes internacionais no manejo da anafilaxia, bem como de disponibilizar a adrenalina autoinjetável, a fim de melhorar o atendimento e evitar um desfecho fatal.


Subject(s)
Humans , Attitude of Health Personnel , Epinephrine/administration & dosage , Practice Guidelines as Topic , Adrenergic Agonists/administration & dosage , Anaphylaxis/diagnosis , Anaphylaxis/drug therapy , Physicians/statistics & numerical data , Self Administration , Injections, Intramuscular
8.
Acta cir. bras ; 32(8): 662-672, Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-886229

ABSTRACT

Abstract Purpose: To determine if the combination of lidocaine with epinephrine or gamma globulin would decrease the rate or reduce the amount of local absorption of lidocaine through the airway. Methods: Twenty adult male cats were randomly and evenly distributed into four groups: 1) Group LG: lidocaine administered with gamma globulin; 2) Group LS: lidocaine administered with physiological saline); 3) Group LE: lidocaine administered with epinephrine; 4) Group C: control group. Invasive blood pressure, heart rate, and concentration of lidocaine were recorded before and after administration. Results: The peak of plasma concentrations appeared difference (Group LG: 1.39 ± 0.23 mg/L; Group LS: 1.47 ± 0.29 mg/L and Group LE: 0.99 ± 0.08 mg/L). Compared to Group C, there were significant differences in the average heart rate of Groups LG, LS, and LE (P < 0.05). The average systolic blood pressures were significantly different when each group was compared to Group C (P < 0.05). The biological half-life, AUC0-120, peak time, and half-life of absorption among the three groups have not presented statistically significant differences (P > 0.05). Conclusion: Administering lidocaine in combination with gamma globulin through airway causes significant decrease the rate and reduce the amount of local absorption of lidocaine in cats.


Subject(s)
Animals , Male , Cats , gamma-Globulins/pharmacokinetics , Epinephrine/pharmacokinetics , Adrenergic beta-Agonists/pharmacokinetics , Respiratory Tract Absorption/drug effects , Anesthetics, Local/pharmacokinetics , Lidocaine/pharmacokinetics , Reference Values , Time Factors , Trachea/drug effects , Blood Pressure/drug effects , Bronchoscopy/methods , gamma-Globulins/administration & dosage , Epinephrine/administration & dosage , Random Allocation , Reproducibility of Results , Adrenergic beta-Agonists/administration & dosage , Drug Combinations , Heart Rate/drug effects , Anesthetics, Local/administration & dosage , Anesthetics, Local/blood , Lidocaine/administration & dosage , Lidocaine/blood
9.
Rev. bras. cir. cardiovasc ; 32(3): 177-183, May-June 2017. tab, graf
Article in English | LILACS | ID: biblio-897904

ABSTRACT

Abstract Introduction: Few data can be found about cardiac arrest in the intensive care unit outside reference centers in third world countries. Objective: To study epidemiology and prognostic factors associated with cardiac arrest in the intensive care unit (ICU) in an average Brazilian center. Methods: Between June 2011 and July 2014, 302 cases of cardiac arrest in the intensive care unit were prospectively evaluated in 273 patients (age: 68.9 ± 15 years) admitted in three mixed units. Data regarding cardiac arrest and cardiopulmonary resuscitation were collected in an "Utstein style" form and epidemiologic data was prospectively obtained. Factors associated with do not resuscitate orders, return of spontaneous circulation and survival were studied using binary logistic regression. Statistical package software used was SPSS 19.0 (IBM Inc., USA). Results: Among 302 cardiac arrests, 230 (76.3%) had their initial rhythm recorded and 141 (61.3%) was in asystole, 62 (27%) in pulseless electric activity (PEA) and 27 had a shockable rhythm (11.7%). In 109 (36.1%) cases, cardiac arrest had a suspected reversible cause. Most frequent suspected cardiac arrest causes were hypotension (n=98; 32.5%), multiple (19.2%) and hypoxemia (17.5%). Sixty (19.9%) cardiac arrests had do not resuscitate orders. Prior left ventricle dysfunction was the only predictor of do not resuscitate order (OR: 3.1 [CI=1.03-9.4]; P=0.04). Among patients that received cardiopulmonary resuscitation, 59 (24.4%) achieved return of spontaneous circulation and 12 survived to discharge (5.6%). Initial shockable rhythm was the only return of spontaneous circulation predictor (OR: 24.9 (2.4-257); P=0.007) and survival (OR: 4.6 (1.4-15); P=0.01). Conclusion: Cardiopulmonary resuscitation rate was high considering ICU patients, so was mortality. Prior left ventricular dysfunction was a predictor of do not resuscitate order. Initial shockable rhythm was a predictor of return of spontaneous circulation and survival.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Cardiopulmonary Resuscitation/mortality , Cardiopulmonary Resuscitation/standards , Heart Arrest/mortality , Heart Arrest/therapy , Intensive Care Units/statistics & numerical data , Prognosis , Time Factors , Brazil , Epinephrine/administration & dosage , Logistic Models , Prospective Studies , Risk Factors , Resuscitation Orders , Hospital Mortality , Statistics, Nonparametric , Adrenergic Agonists/pharmacology , Heart Arrest/etiology
10.
Rev. bras. anestesiol ; 67(2): 217-220, Mar.-Apr. 2017.
Article in English | LILACS | ID: biblio-843378

ABSTRACT

Abstract We report a case of perianesthetic refractory anaphylactic shock with cefuroxime in a patient with history of penicillin allergy on regular therapy with atenolol, losartan, prazosin and nicardipine. Severe anaphylactic shock was only transiently responsive to 10 mL of (1:10,000) epinephrine and needed norepinephrine and dopamine infusion. Supportive therapy with vasopressors and inotropes along with mechanical ventilation for the next 24 hours resulted in complete recovery. She was successfully operated upon 2 weeks later with the same anesthetic drugs but intravenous ciprofloxacin as the alternative antibiotic for perioperative prophylaxis.


Resumo Relatamos um caso de choque anafilático refratário no período perianestésico com cefuroxima em paciente com história de alergia à penicilina em terapia regular com atenolol, losartan, prazosina e nicardipine. O choque anafilático grave foi apenas transitoriamente responsivo a 10 mL de epinefrina (1:10000) e precisou de infusão de norepinefrina e dopamina. A terapia de apoio com vasopressores e inotrópicos, juntamente com ventilação mecânica por 24 horas, resultou em recuperação completa. A paciente foi operada com sucesso duas semanas mais tarde, com os mesmos agentes anestésicos, mas com ciprofloxacina intravenosa como antibiótico opcional para a profilaxia perioperatória.


Subject(s)
Humans , Female , Cefuroxime/adverse effects , Anaphylaxis/chemically induced , Anti-Bacterial Agents/adverse effects , Antihypertensive Agents/administration & dosage , Penicillins/adverse effects , Respiration, Artificial/methods , Dopamine/administration & dosage , Epinephrine/administration & dosage , Norepinephrine/administration & dosage , Cefuroxime/administration & dosage , Drug Hypersensitivity/etiology , Anesthetics/administration & dosage , Middle Aged , Anti-Bacterial Agents/administration & dosage
12.
Rev. bras. oftalmol ; 75(6): 425-431, nov.-dez. 2016. tab
Article in English | LILACS | ID: biblio-829978

ABSTRACT

ABSTRACT Objective: To evaluate pupillary size and vital signs following intraoperative intracameral adrenaline during phacoemulsification and postoperative effect of on co specular microscopy findings and macular thickness by OCT. Methods: A prospective interventional study carried out from December 2014 to December 2015 on 90 eyes. They were divided randomly into further 6 groups (15 each). The inclusion criteria consisted of no history of ocular pathologic conditions, trauma, previous ocular surgery, or recent ocular medication use. All patients were dilated preoperatively by phenylephrine 10% and operated under local peribulbar anesthesia. Then systemic monitoring regarding (pulse rate, blood pressure) and measurement of the horizontal pupil diameter by a caliper to the nearest 0.25mm pre and post intracameral adrenaline injection. Results: In our study there were great effect for intracameral epinephrine, with concentrations used, in dilatation and maintainance of papillary dilatation, The mean pre intracameral epinephrine was 4.53± 1.27 mm.The mean post epinephrine papillary diameter was 6.46± 1.00 mm. Three cases from group 1/10000 weren't dilated properly. Also three cases from group 1/9000 weren't dilated properly after intracameral epinephrine. Conclusion: Intracameral epinephrine even in higher concentrations is effective in papillary dilatation especially in cases with long duration and poorly dilated cases by usual topical mydriatics.


Subject(s)
Humans , Male , Female , Dilatation , Epinephrine/administration & dosage , Phacoemulsification , Pupil/drug effects , Tomography, Optical Coherence , Clinical Trial , Prospective Studies
13.
Rev. bras. anestesiol ; 66(1): 63-71, Jan.-Feb. 2016. graf
Article in Portuguese | LILACS | ID: lil-773483

ABSTRACT

BACKGROUND AND OBJECTIVES: Review of various techniques for digital blocks with local anesthetic, with or without epinephrine. CONTENTS: Description of various procedures and comparison of results reported in the literature, mainly on latency and quality of anesthesia, details on vasoconstrictor effect of epinephrine, intraoperative bleeding, necessity of tourniquet use, duration of anesthesia and postoperative analgesia, blood flow and digital SpO2 behavior, local and systemic complications, and also approaches and drugs to be used in certain situations of ischemia. CONCLUSIONS: The advantages of adding epinephrine to the anesthetic solution are minor when compared to the risks of the procedure, and it seems dangerous to use a vasoconstrictor in the fingers, unless the safety of the technique and the possibility of discarding the tourniquet are definitely proven.


JUSTIFICATIVA E OBJETIVOS: Revisão das diversas técnicas para bloqueios em dedos de mãos, com anestésico local associado ou não à epinefrina. CONTEÚDO: São descritos os procedimentos usados e comparados os resultados obtidos na literatura, principalmente em relação a: latência e qualidade da anestesia, detalhes sobre o efeito vasoconstritor da epinefrina, sangramento intraoperatório, necessidade ou não do uso de torniquete, duração da anestesia e da analgesia pós-operatórias, comportamento do fluxo arterial e da SpO2 digitais, complicações locais e sistêmicas e, ainda, condutas e medicamentos a serem usados em determinadas situações de isquemia. CONCLUSÕES: As vantagens da inclusão de epinefrina na solução anestésica são de pouca importância quando comparadas aos riscos do procedimento e parece perigoso usar o vasoconstritor em dedos de mão, a não ser que fiquem definitivamente comprovadas a inocuidade da técnica e a possibilidade do descarte do torniquete.


Subject(s)
Humans , Epinephrine/administration & dosage , Anesthetics, Local/administration & dosage , Nerve Block/methods , Tourniquets/statistics & numerical data , Vasoconstrictor Agents/administration & dosage , Vasoconstrictor Agents/adverse effects , Epinephrine/adverse effects , Blood Loss, Surgical , Fingers , Anesthetics, Local/adverse effects , Nerve Block/adverse effects
14.
In. Kalil Filho, Roberto; Fuster, Valetim; Albuquerque, Cícero Piva de. Medicina cardiovascular reduzindo o impacto das doenças / Cardiovascular medicine reducing the impact of diseases. São Paulo, Atheneu, 2016. p.955-986.
Monography in Portuguese | LILACS | ID: biblio-971577
17.
J. oral res. (Impresa) ; 4(5): 306-312, oct.2015. ilus
Article in English | LILACS | ID: lil-783353

ABSTRACT

To determine the effectiveness of warming anesthetic solutions on pain produced during the administration of anesthesia in maxillary dental infiltration technique. Material and Methods: A double-blind cross-over clinical study was designed. Fifty-six volunteer students (mean age 23.1+/-2.71 years) of the Dental School at Universidad Austral de Chile (Valdivia, Chile) participated in the study. Subjects were given 0.9ml of 2 percent lidocaine with 1:100.000 epinephrine (Alphacaine®; Nova DFL - Brazil) by two punctions at buccal vestibule of lateral incisor. Warm anesthesia at 42°C(107.6°F) was administered in a hemi-arch; and after one week anesthesia at room temperature (21°C; 69.8°F) and at a standardized speed was administered at the contralateral side. The intensity of pain felt during injection was registered and compared using visual analog scale (VAS) of 100mm (Wilcoxon test p<0.05). Results: The use of anesthesia at room temperature caused a VAS-pain intensity of 34.2+/-16.6mm, and anesthesia at 42°C a VAS-pain intensity of 15.7+/-17.4mm (p<0.0001). Conclusion: The use of anesthesia at42°C resulted in a significantly lower pain intensity perception during injection compared with the use of anesthesia at room temperature during maxillary infiltration technique...


Determinar la efectividad del calentamiento de anestesia en la reducción del dolor producidodurante la administración de anestesia dental en técnica infiltrativa maxilar. Material y método: Se diseñó un estudio clínico doble ciego de brazos cruzados.Participaron cincuenta y seis estudiantes voluntarios (23.1+/-2.71 años) de la Escuela de Odontología de la Universidad Austral de Chile (Valdivia, Chile). Se les administró 0.9ml de lidocaína 2 por ciento con epinefrina 1:100.000 (Alphacaine®; Nova DFL - Brasil) mediante 2 punciones en el fondo de vestíbulo a nivel del incisivo lateral superior. En una hemi-arcada se administró anestesia a 42ºC (107.6°F) y luego de una semana se les administró anestesia en el lado contralateral a temperatura ambiente (21ºC; 69.8°F) con una velocidad estandarizada. Se comparó laintensidad de dolor percibida durante la inyección mediante escala visual análoga (EVA) de 100mm (pruebade Wilcoxon p<0.05). Resultados: El uso de anestesia a temperatura ambiente provocó un dolor promedio EVAde 34.2+/-16.6mm y la anestesia a 42°C un dolor promedio EVA 15.7+/-17.4mm (p<0.0001). Conclusión: El uso de anestesia a 42ºC generó una percepción de dolor significativamente menor durante la inyección del anestésico en comparación a su uso con temperatura ambiente en la técnica infiltrativa maxilar...


Subject(s)
Humans , Male , Adult , Female , Young Adult , Anesthesia, Dental/methods , Anesthetics, Local/administration & dosage , Pain/prevention & control , Lidocaine/administration & dosage , Cross-Sectional Studies , Double-Blind Method , Epinephrine/administration & dosage , Injections/methods , Pain Measurement , Temperature
18.
Rev. bras. anestesiol ; 65(4): 292-297, July-Aug. 2015. tab
Article in English | LILACS | ID: lil-755137

ABSTRACT

BACKGROUND AND OBJECTIVE:

Anaphylaxis remains one of the potential causes of perioperative death, being generally unanticipated and quickly progress to a life threatening situation. A narrative review of perioperative anaphylaxis is performed.

CONTENT:

The diagnostic tests are primarily to avoid further major events. The mainstays of treatment are adrenaline and intravenous fluids.

CONCLUSION:

The anesthesiologist should be familiar with the proper diagnosis, management and monitoring of perioperative anaphylaxis.

.

ANTECEDENTES E OBJETIVO:

A anafilaxia continua sendo uma das causas potenciais de morte perioperatória, pois geralmente não é prevista e evolui rapidamente para uma situação ameaçadora da vida. Uma revisão da anafilaxia perioperatória é feita.

CONTEÚDO:

O exames diagnósticos são importantes principalmente para evitar eventos posteriores. Os pilares do tratamento são a adrenalina e os líquidos intravenosos.

CONCLUSÃO:

O anestesiologista deve estar familiarizado com o diagnóstico oportuno, manejo e monitoramento da anafilaxia perioperatória.

.

ANTECEDENTES Y OBJETIVO:

La anafilaxia sigue siendo una de las causas potenciales de muerte perioperatoria por ser generalmente no anticipada, y progresar rápidamente a una situación amenazante de la vida. Se realiza una revisión de la anafilaxia perioperatoria.

CONTENIDO:

Las pruebas diagnósticas son importantes principalmente para evitar eventos posteriores. Los pilares del tratamiento son la adrenalina y los líquidos intravenosos.

CONCLUSIÓN:

El anestesista debe estar familiarizado con el diagnóstico oportuno, manejo y seguimiento de la anafilaxia perioperatoria.

.


Subject(s)
Humans , Hypersensitivity, Immediate/epidemiology , Anaphylaxis/epidemiology , Intraoperative Complications/epidemiology , Epinephrine/administration & dosage , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology , Drug Hypersensitivity/epidemiology , Fluid Therapy/methods , Hypersensitivity, Immediate/diagnosis , Hypersensitivity, Immediate/etiology , Anaphylaxis/diagnosis , Anaphylaxis/etiology , Intraoperative Complications/diagnosis , Anesthesiology/methods
19.
Arch. argent. pediatr ; 113(1): 81-: I-87, II, ene. 2015. tab
Article in Spanish | LILACS, BINACIS | ID: biblio-1159660

ABSTRACT

En 1998, la Sociedad Argentina de Pediatría publicó la recomendación del tratamiento del choque anafiláctico. Mientras en dicha recomendación se sugería el uso de adrenalina por vía subcutánea, actualmente se considera la vía intramuscular como la más adecuada. Aspectos farmacodinámicos determinan esta preferencia. Para el tratamiento extrahospitalario, el uso de autoinyectores de manera correcta puede colaborar en el control rápido y eficaz de la afección. El uso del resto de las medicaciones propuestas en la recomendación de 1998 se mantiene sin cambios.


In 1998, the Sociedad Argentina de Pediatría issued the recommendation of the treatment of anaphylactic shock. While this recommendation suggested the use of subcutaneous epinephrine, currently the intramuscular via is considered the most appropriate one. Pharmacological aspects determine this preference. For outpatient treatment, the correct use of autoinjectors can control anaphylaxis quickly and effectively. The use of other medications in the proposed 1998 recommendation remains unchanged.


Subject(s)
Humans , Child , Epinephrine/administration & dosage , Anaphylaxis/drug therapy
20.
Rev. chil. anest ; 44(2): 121-130, 2015. tab
Article in Spanish | LILACS | ID: biblio-831319

ABSTRACT

The Advanced Cardiac Life Support proposes the use of vasopressor drugs cardiopulmonary resuscitation, with the primary purpose of effectively and early restoration of spontaneous circulation. However, the increased return of spontaneous circulation with vasopressors has not improved neurological outcome at hospital discharge. Adrenaline has traditionally been the main tool of the cardiopulmonary resuscitation guidelines despite the lack of conclusive scientific evidence. Therefore other alternatives were considered at experimental level that has have failed to overcome the clinical results of this drug. In contrast to progress on the standardized management of cardiopulmonary resuscitation, the controversy regarding the effectiveness of vasopressor therapy remains open in the last years due to lack of clinical data to support their usefulness.


El soporte vital avanzado propone el uso de vasopresores durante la resucitación cardiopulmonar, con la finalidad primordial de reestablecer de manera precoz y efectiva la circulación espontánea. Sin embargo, el aumento del retorno a la circulación espontánea asociada a los vasopresores no ha demostrado una mejoría en el pronóstico neurológico al alta hospitalaria. La adrenalina, ha sido tradicionalmente la herramienta principal de las guías de resucitación cardiopulmonar pese a la falta de evidencia científica concluyente. Por ello se han planteado otras alternativas a nivel experimental que no han logrado superar los resultados de este fármaco a nivel clínico. En contraste con los avances respecto al manejo estandarizado de la resucitación cardiopulmonar, el debate con respecto a la efectividad de la terapia vasopresora se mantiene abierto en los últimos años dada la falta de datos clínicos que corroboren su real utilidad.


Subject(s)
Humans , Epinephrine/administration & dosage , Heart Arrest/drug therapy , Cardiopulmonary Resuscitation/methods , Vasoconstrictor Agents/administration & dosage , Vasopressins/administration & dosage , Advanced Cardiac Life Support
SELECTION OF CITATIONS
SEARCH DETAIL